Format

Send to

Choose Destination
J Am Coll Cardiol. 2014 Jul 22;64(3):304-18. doi: 10.1016/j.jacc.2014.05.027.

The MOGE(S) classification of cardiomyopathy for clinicians.

Author information

1
Center for Inherited Cardiovascular Diseases, IRCCS Foundation Policlinico San Matteo, Pavia, Italy.
2
Weill Cornell Medical College, New York, New York.
3
GVM Care & Research, E.S. Health Science Foundation, Maria Cecilia Hospital, Cotignola, Italy.
4
University of Pavia, Pavia, Italy.
5
St. Luke's Medical Center, Milwaukee, Wisconsin.
6
Northwestern University School of Medicine, Chicago, Illinois.
7
Icahn School of Medicine at Mount Sinai, New York, New York.
8
Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: Narula@mountsinai.org.

Erratum in

  • J Am Coll Cardiol. 2014 Sep 16;64(11):1186. Bonow, Robert D [Corrected to Bonow, Robert O].

Abstract

Most cardiomyopathies are familial diseases. Cascade family screening identifies asymptomatic patients and family members with early traits of disease. The inheritance is autosomal dominant in a majority of cases, and recessive, X-linked, or matrilinear in the remaining. For the last 50 years, cardiomyopathy classifications have been based on the morphofunctional phenotypes, allowing cardiologists to conveniently group them in broad descriptive categories. However, the phenotype may not always conform to the genetic characteristics, may not allow risk stratification, and may not provide pre-clinical diagnoses in the family members. Because genetic testing is now increasingly becoming a part of clinical work-up, and based on the genetic heterogeneity, numerous new names are being coined for the description of cardiomyopathies associated with mutations in different genes; a comprehensive nosology is needed that could inform the clinical phenotype and involvement of organs other than the heart, as well as the genotype and the mode of inheritance. The recently proposed MOGE(S) nosology system embodies all of these characteristics, and describes the morphofunctional phenotype (M), organ(s) involvement (O), genetic inheritance pattern (G), etiological annotation (E) including genetic defect or underlying disease/substrate, and the functional status (S) of the disease using both the American College of Cardiology/American Heart Association stage and New York Heart Association functional class. The proposed nomenclature is supported by a web-assisted application and assists in the description of cardiomyopathy in symptomatic or asymptomatic patients and family members in the context of genetic testing. It is expected that such a nomenclature would help group cardiomyopathies on their etiological basis, describe complex genetics, and create collaborative registries.

KEYWORDS:

cardiomyopathy; classification; genetics

PMID:
25034069
DOI:
10.1016/j.jacc.2014.05.027
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center